1. Home
  2. EVGOW vs VCEL Comparison

EVGOW vs VCEL Comparison

Compare EVGOW & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo EVgo Inc.

EVGOW

EVgo Inc.

HOLD

Current Price

$0.03

Market Cap

0.0

ML Signal

HOLD

Logo Vericel Corporation

VCEL

Vericel Corporation

HOLD

Current Price

$34.04

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EVGOW
VCEL
Founded
2010
1989
Country
United States
United States
Employees
376
N/A
Industry
Other Specialty Stores
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
1.7B
IPO Year
N/A
1996

Fundamental Metrics

Financial Performance
Metric
EVGOW
VCEL
Price
$0.03
$34.04
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$58.50
AVG Volume (30 Days)
20.6K
739.5K
Earning Date
03-07-2025
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
60.00
EPS
N/A
0.32
Revenue
$239,306,000.00
$276,259,000.00
Revenue This Year
N/A
$19.10
Revenue Next Year
N/A
$17.95
P/E Ratio
N/A
$104.02
Revenue Growth
73.08
16.45
52 Week Low
$0.01
$28.95
52 Week High
$0.38
$45.97

Technical Indicators

Market Signals
Indicator
EVGOW
VCEL
Relative Strength Index (RSI) 39.65 53.21
Support Level $0.01 $30.12
Resistance Level $0.08 $34.34
Average True Range (ATR) 0.00 1.77
MACD 0.00 0.43
Stochastic Oscillator 52.70 79.26

Price Performance

Historical Comparison
EVGOW
VCEL

About EVGOW EVgo Inc.

EVgo Inc is an EV fast charging provider. The company deploys charging infrastructure by partnering with retailers, grocery stores, restaurants, gas stations, rideshare operators, and autonomous vehicle companies across the U.S., and serves the EV commercial segment by deploying fleet-charging solutions for light-duty EV fleets at depot locations, off-site charging hubs, or through its public network. It also owns PlugShare, a platform for EV drivers to locate public charging stations, plan trips and share charging experiences, which also provides charging location data licensing, infrastructure analysis, and EV driver research. It also derives revenue from the sale of regulatory credits earned from participation in LCFS programs and other carbon or emissions trading schemes in the U.S.

About VCEL Vericel Corporation

Vericel Corp is a fully integrated commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

Share on Social Networks: